Gottfriedova Halima, Dezortova Monika, Sedivy Petr, Pajuelo Dita, Burian Martin, Sticova Eva, Snizkova Olga, Honsova Eva, Dolecek Filip, Hajek Milan
Dept. Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 140 21 Prague 4, Czech Republic.
MR-Unit, Dept. Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 140 21 Prague 4, Czech Republic.
Eur J Radiol. 2025 Feb;183:111931. doi: 10.1016/j.ejrad.2025.111931. Epub 2025 Jan 16.
This prospective pilot study aims to evaluate the capabilities of novel quantitative ultrasound (QUS) methods based on attenuation (Att.PLUS) and sound speed (SSp.PLUS) for detecting liver fat.
The study included 56 individuals with biopsy-proven steatosis (percutaneous liver biopsy) ranging from 0 % to 90 % of hepatocytes containing intracellular lipid vacuoles. Histopathology was considered reference standard. Abdominal QUS examinations were conducted using Att.PLUS and SSp.PLUS techniques on the Aixplorer MACH 30 system. Comparative assessments were made using the results of liver biopsy and magnetic resonance spectroscopy (MRS) together with magnetic resonance imaging proton density fat fraction (MRI-PDFF). MR examinations were performed on the Siemens VIDA 3 T system.
ROC analysis was conducted for two groups: (a) patients without steatosis (S0) versus those with steatosis (S1 + S2 + S3) yielded AUC values of 0.79 for Att.PLUS and 0.78 for SSp.PLUS, in contrast to an AUC > 0.95 for MRS and MRI-PDFF; and (b) patients without or with mild steatosis (S0 + S1) versus those with severe steatosis (S2 + S3), yielded AUC values of 0.93 for Att.PLUS and 0.89 for SSp.PLUS, in contrast to an AUC > 0.99 for MRS and MRI-PDFF. However, MR methods were superior in detecting liver fat content in obese patients and post-liver transplantation individuals.
Both QUS parameters (Att.PLUS and SSp.PLUS) appear equivalent at differentiating S0 vs. (S1 + S2 + S3) patients, but the Att.PLUS parameter may be more effective at identifying advanced steatosis (S2 + S3). MR techniques outperformed QUS methods, making them more suitable for clinical studies.
这项前瞻性试点研究旨在评估基于衰减(Att.PLUS)和声速(SSp.PLUS)的新型定量超声(QUS)方法检测肝脏脂肪的能力。
该研究纳入了56例经活检证实患有脂肪变性(经皮肝活检)的个体,其肝细胞内含有细胞内脂质空泡的比例为0%至90%。组织病理学被视为参考标准。使用Att.PLUS和SSp.PLUS技术在Aixplorer MACH 30系统上进行腹部QUS检查。使用肝活检结果、磁共振波谱(MRS)以及磁共振成像质子密度脂肪分数(MRI-PDFF)进行比较评估。MR检查在西门子VIDA 3T系统上进行。
对两组进行了ROC分析:(a)无脂肪变性(S0)的患者与有脂肪变性(S1+S2+S3)的患者相比,Att.PLUS的AUC值为0.79,SSp.PLUS的AUC值为0.78,而MRS和MRI-PDFF的AUC>0.95;(b)无或有轻度脂肪变性(S0+S1)的患者与有重度脂肪变性(S2+S3)的患者相比,Att.PLUS的AUC值为0.93,SSp.PLUS的AUC值为0.89,而MRS和MRI-PDFF的AUC>0.99。然而,MR方法在检测肥胖患者和肝移植后个体的肝脏脂肪含量方面更具优势。
两种QUS参数(Att.PLUS和SSp.PLUS)在区分S0与(S1+S2+S3)患者时似乎相当,但Att.PLUS参数在识别晚期脂肪变性(S2+S3)方面可能更有效。MR技术优于QUS方法,使其更适合临床研究。